| Serial Number | 88461015 |
| Word Mark | ENACT |
| Filing Date | Wednesday, June 5, 2019 |
| Status | 700 - REGISTERED |
| Status Date | Tuesday, December 8, 2020 |
| Registration Number | 6214070 |
| Registration Date | Tuesday, December 8, 2020 |
| Mark Drawing | 4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | Tuesday, May 19, 2020 |
| Goods and Services | Pharmaceuticals and pharmaceutical preparations for human and veterinary use for the treatment and prevention of cancer; vaccine preparations for use in connection with cancer and oncology; antibodies sold as an ingredient of pharmaceuticals for the treatment of cancer; antibodies for use in the production of active ingredients of pharmaceuticals and vaccines for use in connection with cancer and oncology; biological preparations for human medical diagnostics and analysis for use in the treatment of cancer; medical diagnostic reagents for use in connection with cancer and oncology; clinical medical reagents for use in connection with cancer and oncology; biological preparations for medical and veterinary purposes in connection with the treatment of cancer |
| Goods and Services | Research and development in the pharmaceutical and biotechnology fields in connection with cancer and oncology; research and development of medicines in the fields of cancer and oncology; scientific and technological services and research and design services in the fields of cancer and oncology; biological research, clinical research and medical research in the fields of cancer and oncology; chemical and biochemical analysis services in the fields of cancer and oncology; laboratory research in the fields of analytical chemistry, biochemistry, medicinal chemistry, drug development, biotechnology, microbiology and molecular biology in connection with cancer and oncology; clinical research in the fields of cancer and oncology; providing medical and scientific research information in the field of pharmaceuticals in connection with cancer and oncology; Research and development services in the field of antibodies for use in connection with cancer and oncology |
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 006, 018, 044, 046, 051, 052 |
| Class Status Code | 6 - Active |
| Class Status Date | Wednesday, June 19, 2019 |
| Primary Code | 005 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Wednesday, June 19, 2019 |
| Primary Code | 042 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| Party Name | INCYTE HOLDINGS CORPORATION |
| Party Type | 31 - New Owner After Registration |
| Legal Entity Type | 03 - Corporation |
| Address | WILMINGTON, DE 19803 |
| Party Name | MorphoSys AG |
| Party Type | 30 - Original Registrant |
| Legal Entity Type | 99 - Other |
| Address | Planegg D-82152 DE |
| Party Name | MorphoSys AG |
| Party Type | 20 - Owner at Publication |
| Legal Entity Type | 99 - Other |
| Address | Planegg D-82152 DE |
| Party Name | MorphoSys AG |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 99 - Other |
| Address | Planegg D-82152 DE |
| Event Date | Event Description |
| Saturday, June 8, 2019 | NEW APPLICATION ENTERED |
| Wednesday, June 19, 2019 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Wednesday, August 21, 2019 | TEAS AMENDMENT ENTERED BEFORE ATTORNEY ASSIGNED |
| Tuesday, March 17, 2020 | INQUIRY TO SUSPENSION E-MAILED |
| Wednesday, August 21, 2019 | TEAS VOLUNTARY AMENDMENT RECEIVED |
| Monday, August 26, 2019 | ASSIGNED TO EXAMINER |
| Tuesday, September 3, 2019 | SUSPENSION LETTER WRITTEN |
| Tuesday, September 3, 2019 | LETTER OF SUSPENSION E-MAILED |
| Tuesday, September 3, 2019 | NOTIFICATION OF LETTER OF SUSPENSION E-MAILED |
| Tuesday, March 17, 2020 | SUSPENSION INQUIRY WRITTEN |
| Tuesday, March 17, 2020 | NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED |
| Wednesday, April 1, 2020 | TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED |
| Thursday, April 9, 2020 | ASSIGNED TO LIE |
| Wednesday, April 29, 2020 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Thursday, April 9, 2020 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Thursday, April 9, 2020 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Thursday, April 9, 2020 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Tuesday, July 14, 2020 | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
| Tuesday, May 19, 2020 | PUBLISHED FOR OPPOSITION |
| Tuesday, May 19, 2020 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Monday, September 14, 2020 | TEAS DELETE 1(B) BASIS RECEIVED |
| Monday, September 14, 2020 | NOTICE OF ALLOWANCE CANCELLED |
| Tuesday, October 27, 2020 | CASE ASSIGNED TO INTENT TO USE PARALEGAL |
| Tuesday, November 3, 2020 | 1(B) BASIS DELETED; PROCEED TO REGISTRATION |
| Tuesday, December 8, 2020 | REGISTERED-PRINCIPAL REGISTER |
| Wednesday, April 24, 2024 | ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY |
| Wednesday, May 1, 2024 | AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP |
| Monday, June 17, 2024 | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED |
| Monday, June 17, 2024 | TEAS CHANGE OF CORRESPONDENCE RECEIVED |
| Monday, June 17, 2024 | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED |
| Monday, June 17, 2024 | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED |
| Monday, June 17, 2024 | TEAS CHANGE OF OWNER ADDRESS RECEIVED |